BPC-157 Research Peptide — Purity, COA & Batch Data
BPC-157 is a fifteen-residue synthetic peptide studied in gastrointestinal, endothelial and angiogenesis-related laboratory models. This file states the sequence, the mass a batch has to show, the two degradation routes worth watching, and the handling notes that matter once the powder is opened.
The useful thing about a BPC-157 file is that the molecule is small enough to characterise completely. Fifteen residues, no disulphide bonds, no glycosylation, no non-natural monomers — so a certificate that cannot state the mass, the purity trace and the fill has simply not been produced properly.
Compound identity
| Sequence (one-letter) | GEPPPGKPADDAGLV |
| Sequence (three-letter) | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Chain length | 15 amino acids, linear, no disulphide bridge |
| Molecular formula | C62H98N16O22 |
| Molecular weight | 1,419.54 g/mol (free peptide) |
| CAS registry | 137525-51-0 |
| Supplied form | Lyophilised white to off-white powder, acetate salt |
| Storage (powder) | −20 °C, desiccated, protected from light |
Salt correction. The acetate form carries counter-ions, so the measured mass and the weighed fill both sit above the free-peptide figure. A certificate that reports 1,419.5 as the observed mass for an acetate lot is reporting a calculated value, not a measured one.
How BPC-157 identity is confirmed lot by lot
Identity is decided by mass, not by a purity percentage. The theoretical monoisotopic mass for the sequence above is 1,419.54; in electrospray the doubly charged ion appears near m/z 710.8 and the singly charged ion near 1,420.3. A lot whose observed ion sits outside the expected window for those adducts is a different molecule, however clean the chromatogram looks.
The second check is the release trace. The BPC-157 peptide elutes as a single main peak on a C18 column with a water/acetonitrile gradient containing 0.1% trifluoroacetic acid; the certificate should carry the gradient, the wavelength and the run time, not only a percentage. Where a supplier reports purity without the method, the number cannot be reproduced and therefore cannot be audited.
- Observed mass against theoretical 1,419.54, with the adduct stated.
- HPLC purity by peak area, with the chromatogram attached to the certificate.
- Appearance and fill weight against the label on the same lot.
- Retention time consistent with the method described on the certificate.
Purity, impurities and what the COA should show
BPC-157 purity is usually reported as a single HPLC figure, but the two degradation routes that actually appear in stored material are deamidation at the aspartate residues and truncation at the proline-rich N-terminus. Neither is visible unless the method resolves the region in front of the main peak, which is why a method summary matters more than a headline purity figure.
Deamidation and truncation
Deamidation converts an Asp residue to iso-aspartate and shifts the mass by +1 Da; truncation removes one or more N-terminal residues and shifts it by a defined peptide mass. Both appear as earlier-eluting shoulders, and both are detectable on a method that runs long enough to separate them. A certificate reporting 99% with a short run may simply not be looking.
Water content and fill
Lyophilised peptide is hygroscopic. The certificate should state the appearance and the fill weight, and where the lot is sold by mass the weighed fill belongs on the packing record. Purity by HPLC says nothing about moisture, salts or fill, and those are the three things a receiving lab checks first.
- Purity by HPLC with the trace, not only a percentage.
- Mass confirmation with the observed ion stated.
- Appearance and fill weight on the same lot number.
- Storage instruction the release data was based on.
- Method summary: column, gradient, wavelength, run time.
Reconstitution and storage for laboratory stock
BPC-157 dissolves readily in water and in normal saline; stock solutions in the 1–5 mg/mL range are routine. Add the solvent down the vial wall rather than onto the cake, swirl rather than vortex, and let the powder wet out before judging whether it has dissolved. Foam on the surface is not undissolved material.
| Solvent | Sterile water or normal saline; bacteriostatic water where a multi-draw stock is needed |
| Working stock | 1–5 mg/mL, prepared fresh where possible |
| Filtration | 0.22 µm if the stock must be particle-free; expect some loss to the membrane |
| Aliquoting | Freeze single-use aliquots at −20 °C rather than refreezing the parent vial |
| Light | Amber vial or foil wrap; the aromatic residues are the light-sensitive part |
| Powder storage | −20 °C, desiccated; allow the vial to reach room temperature before opening |
One freeze, one thaw. Repeated freeze–thaw cycles are the most common cause of a shoulder appearing in a working stock that was clean on release. Aliquot on the first day and discard what is left in a thawed aliquot.
Ordering BPC-157: pack sizes and batch documents
The BPC-157 peptide is held as ten-vial kits in two fills, with single vials and larger quantities quoted per line. Every kit ships with the BPC-157 COA issued against its own lot; the certificate number and the vial label carry the same lot string.
| Pack | Format | Price |
|---|---|---|
| 5 mg × 10 vials | 10-vial kit | $40 |
| 10 mg × 10 vials | 10-vial kit | $70 |
A BPC-157 supplier that cannot put the lot certificate in front of you before an order is not one to quote against. Prices are per kit as listed at the time of writing and are confirmed on the product page and in the quotation. Bulk quantities, mixed lines and export documentation are quoted per line through bulk research peptides.
Related reading on BPC-157
Need the certificate for the lot that will ship?
Send the pack size you are evaluating. We return the sequence, the theoretical mass, the release method summary and the batch certificate for that specific lot.
